Pharmaceutical Technology ePT Weekly: Having trouble viewing this e-mail? Click here.

News Industry Briefs Webcasts Events About Us

Webcast: Risk Mitigation for Alcohol-Dose Dumping in Controlled Release Forms (May 23) Sponsored by FMC Webcast: Cleaning Validation: Science, Risk, and Novel Approaches to Testing (June 4) Sponsored by Patheon More Webcasts World Biotechnology Congress 2013 June 3-6, 2013 Boston, USA Late Stage Pharma Lifecycle Management June 4-5, 2013 Brussels, Belgium Advertisement: Pharmaceutical Technology Solid Dosage Combo Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid dosage form principles such as solid oral dosage forms, powders, mixing and blending, excipients, tableting, and coating. Stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development. Click here

May 23, 2013 PharmTech.com PRINT SUBSCRIBE DIGITAL SUBSCRIBE Should Regulation of Combination Products Become More Centralized in Europe? While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach. Regulatory Roundup More changes at OGD, FDA budget crunch, and more. Regulatory Convergence Sought for Global Pharma Market Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight. Advertisement: FREE WHITEPAPER: The Key to Tableting Success Learn about common pitfalls, critical questions to ask your tooling provider, and the basics of tool steel selection. Learn More! Actavis to Acquire Warner Chilcott Actavis and Warner Chilcott have entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued at approximately $8.5 billion. Legislation to Protect Subjects in Clinical Trials Introduced Legislation designed to protect clinical trial study participants, close loopholes, and bring certainty and public transparency to research studies, has been introduced. Advertisement: Cleaning Validation: Science, Risk, and Novel Approaches to Testing Live Webcast: Tuesday, June 4, 2013 at 11:00 am EDT Register Free at www.pharmtech.com/testing Report Previews Future of US Biosimilar Market Thomson Reuters released a report that provides a view of the challenges facing companies entering the United States biosimilar drug market. Advertisement: Avoid the 483–Unconventional Approaches to Elevate Your Quality Program On Demand Webcast Register Free at www.spectroscopyonline.com/ramananalysis AstraZeneca Provides Update on Oncology Pipeline AstraZeneca announced that three of its cancer compounds—moxetumomab pasudotox, olaparib, and selumetinib—will be moving forward to Phase III clinical development. Advertisement: Risk Mitigation for Alcohol-Dose Dumping in Controlled Release Forms On Demand Webcast Register Free at www.pharmtech.com/alcohol Abbvie and Galapagos Extend Collaboration AbbVie and Galapagos have extended their collaboration on the clinical development of GLPG0634 to include Crohn’s disease. USP Offers Herbal Medicines Compendium The US Pharmacopeial Convention is offering free online access to public standards to help ensure the quality of the herbal ingredients used in medicinal products. Theravance and Elan Enter $1 Billion Royalty Participation Agreement Elan will purchase interest in four respiratory programs.

What has been the most significant benefit of applying quality-by-design (QbD) principles? Better process understanding: 67%   Increased efficiency or reduced waste 9%       Shorter process times 5%       Reduced expenses 4%       Improved ease of making changes 15%       This week we would like to know... How does your company apply quality-by-design (QbD) principles to manufacturing processes? Contact Us Click here to contact editorial. Click here to contact sales.

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |